Mediclin AG
XETRA:MED
Mediclin AG
Cost of Revenue
Mediclin AG
Cost of Revenue Peer Comparison
Competitive Cost of Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Mediclin AG
XETRA:MED
|
Cost of Revenue
-€136.6m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-2%
|
|
Rhoen Klinikum AG
XETRA:RHK
|
Cost of Revenue
-€500.2m
|
CAGR 3-Years
-6%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
4%
|
|
M1 Kliniken AG
XETRA:M12
|
Cost of Revenue
-€247m
|
CAGR 3-Years
-72%
|
CAGR 5-Years
-48%
|
CAGR 10-Years
N/A
|
|
Limes Schlosskliniken AG
XETRA:LIK
|
Cost of Revenue
-€1.2m
|
CAGR 3-Years
-46%
|
CAGR 5-Years
-29%
|
CAGR 10-Years
N/A
|
|
MATERNUS-Kliniken-AG
XETRA:MAK
|
Cost of Revenue
-€19.7m
|
CAGR 3-Years
3%
|
CAGR 5-Years
2%
|
CAGR 10-Years
N/A
|
|
Eifelhoehen-Klinik AG
F:EIF
|
Cost of Revenue
-€2.7m
|
CAGR 3-Years
-33%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
See Also
What is Mediclin AG's Cost of Revenue?
Cost of Revenue
-136.6m
EUR
Based on the financial report for Mar 31, 2024, Mediclin AG's Cost of Revenue amounts to -136.6m EUR.
What is Mediclin AG's Cost of Revenue growth rate?
Cost of Revenue CAGR 10Y
-2%
Over the last year, the Cost of Revenue growth was -1%. The average annual Cost of Revenue growth rates for Mediclin AG have been -7% over the past three years , -3% over the past five years , and -2% over the past ten years .